Title:
HIV-1 VIRUS TAT-PROTEIN MUTANTS
Kind Code:
A1
Abstract:
Abstract not available for EP1463819
Abstract of corresponding document: US2005164164
The invention relates to the use of a protein mutation method for preparing detoxified and immunogenic mutants of the wild-type HIV-1 virus Tat-protein. The invention also relates to a method for preparing detoxified and immunogenic mutants of the wild-type HIV-1 virus Tat-protein, comprising a first step in which wild-type Tat-protein mutants are prepared, a second step in which detoxified mutants having no transcellular activity but an altered nuclear localization are screened, and a third step in which immunogenic mutants capable of inducing antibodies directed against both mutants and the wild Tat protein are screened. Steps two and three are reversible.

Inventors:
Guillon, Christophe (FR)
Chedal-bornu, Aurelie (FR)
Verrier, Bernard (FR)
Mandrand, Bernard (FR)
Application Number:
EP20030709864
Publication Date:
10/06/2004
Filing Date:
01/09/2003
View Patent Images:
Export Citation:
Assignee:
Biomerieux SA. (FR)
International Classes:
A61K39/21; A61K39/21; A61P31/00; A61P31/18; C07K14/005; C07K14/16; C12N15/40; C12N15/48; C12N15/49; (IPC1-7): C12N15/49; A61K39/21; C07K14/16; C07K16/10; C12N5/10; G01N33/53; G01N33/566
European Classes:
A61K39/21; C07K14/16F
Other References:
See references of WO 03057885A1




<- Previous Patent (TRANSPORTERS AND ION...)   |   Next Patent (METHOD OF SCREENING ...) ->